#Genetics

The receipts for the body layer of the control grid — biometric ID, identity-tied CBDC, brain-computer interfaces, genetic databases, programmable molecular platforms, and continuous monitoring — each advancing program paired with its own documented limit.

How a reproductive trajectory once private to adults became a routed transaction across a vendor stack — algorithmic child-welfare scoring, polygenic embryo screening, genetic-database property fights, biometric identity gating, clinical AI selection, and the 'good genes' rhetoric around it — each layer sourced, with contested efficacy claims kept attributed to the company that makes them.

How the Chapter 11 bankruptcy of 23andMe transferred roughly 15 million customer genetic profiles to a founder-controlled nonprofit through a court-supervised sale rather than individual re-consent.